NOFNOF CORPORATION4403東証プライム化学FY ending Mar 2026, consolidated, J-GAAP

NOF revenue and profit

Out of every ¥100 of sales, about ¥18 is left as operating profit. Revenue changed +8.2% from the prior year, operating profit +4.6%.

Five-year trend

Revenue¥258B
FY ending Mar 2022: ¥192.6B¥192.6BFY ending Mar 2023: ¥217.7B¥217.7BFY ending Mar 2024: ¥222.3B¥222.3BFY ending Mar 2025: ¥238.3B¥238.3BFY ending Mar 2026: ¥258B¥258BFY22FY23FY24FY25FY26
Operating income¥47.4B
FY ending Mar 2022: ¥35.6B¥35.6BFY ending Mar 2023: ¥40.6B¥40.6BFY ending Mar 2024: ¥42.1B¥42.1BFY ending Mar 2025: ¥45.3B¥45.3BFY ending Mar 2026: ¥47.4B¥47.4BFY22FY23FY24FY25FY26
Operating margin18.4%
FY ending Mar 2022: 18.5%18.5%FY ending Mar 2023: 18.7%18.7%FY ending Mar 2024: 19.0%19.0%FY ending Mar 2025: 19.0%19.0%FY ending Mar 2026: 18.4%18.4%FY22FY23FY24FY25FY26

What drives ROE

Net margin × asset turnover = ROA; ROA × financial leverage = ROE

Net margin15.7%
Asset turnover0.68×
ROA10.7%
ROA10.7%
Financial leverage1.51×
ROE16.1%

Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.

Net margin15.7%
2022: 13.9%13.9%2023: 15.6%15.6%2024: 15.3%15.3%2025: 15.3%15.3%2026: 15.7%15.7%2223242526
Asset turnover0.68×
2022: 0.67×0.67×2023: 0.73×0.73×2024: 0.68×0.68×2025: 0.68×0.68×2026: 0.68×0.68×2223242526
ROA10.7%
2022: 9.2%9.2%2023: 11.3%11.3%2024: 10.4%10.4%2025: 10.4%10.4%2026: 10.7%10.7%2223242526
Financial leverage1.51×
2022: 1.48×1.48×2023: 1.46×1.46×2024: 1.46×1.46×2025: 1.46×1.46×2026: 1.51×1.51×2223242526
ROE16.1%
2022: 13.6%13.6%2023: 16.6%16.6%2024: 15.2%15.2%2025: 15.3%15.3%2026: 16.1%16.1%2223242526
PeriodNet marginAsset turnoverROAFinancial leverageROE
202213.9%0.67×9.2%1.48×13.6%
202315.6%0.73×11.3%1.46×16.6%
202415.3%0.68×10.4%1.46×15.2%
202515.3%0.68×10.4%1.46×15.3%
202615.7%0.68×10.7%1.51×16.1%

Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.

Asset intensity and goodwill

Annual trends in tangible-asset ratios and goodwill balance.

PPE ÷ revenue37.5%
2021: 36.0%36.0%2022: 32.2%32.2%2023: 29.3%29.3%2024: 33.6%33.6%2025: 35.7%35.7%2026: 37.5%37.5%212223242526
PPE ÷ total assets24.2%
2021: 22.9%22.9%2022: 21.4%21.4%2023: 20.6%20.6%2024: 21.9%21.9%2025: 23.8%23.8%2026: 24.2%24.2%212223242526

Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition

Investment and working-capital efficiency

Track R&D investment and how long operating capital remains tied up before sales turn into cash.

R&D spending¥8.07B
2021: ¥5.76B¥5.76B2022: ¥6.11B¥6.11B2023: ¥6.57B¥6.57B2024: ¥7.25B¥7.25B2025: ¥7.93B¥7.93B2026: ¥8.07B¥8.07B212223242526
R&D / revenue3.1%
2021: 3.3%3.3%2022: 3.2%3.2%2023: 3.0%3.0%2024: 3.3%3.3%2025: 3.3%3.3%2026: 3.1%3.1%212223242526
Receivable days—
2021: 84d84d212223242526
Payable days46d
2021: 54d54d2022: 63d63d2023: 48d48d2024: 56d56d2025: 53d53d2026: 46d46d212223242526

R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.

Income statement (JPY millions)

ItemFY ending Mar 2022FY ending Mar 2023FY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Revenue192,642217,709222,252238,310257,967
Cost of revenue123,713141,766142,762153,156168,874
Gross profit68,92875,94379,49085,15389,092
SG&A33,33335,31837,34839,84541,681
Operating income35,59540,62442,14245,30847,411
Pretax income37,97748,04048,46850,77857,329
Income tax11,25514,02514,40714,17316,671
Net income attributable to owners26,69033,97333,99036,49740,550
Operating margin18.5%18.7%19.0%19.0%18.4%

Balance sheet (reported items)

Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.

Assets

Cash 21%
Property, plant and equipment 24%
0%
Investment securities 12%
Other assets 43%

Funding

6%
Other liabilities 20%
Equity 74%

Each bar totals 100% of assets; other is the residual.

ItemFY ending Mar 2022FY ending Mar 2023FY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Cash and equivalents¥81.4B¥89.1B¥87.5B¥82.7B¥83B
Total assets¥289.6B¥309.4B¥341.4B¥357.2B¥399.2B
Net assets¥221.7B¥240B¥265.9B¥279.6B¥296.5B
Share capital¥17.7B¥17.7B¥17.7B¥17.7B¥17.7B
Property, plant and equipment¥61.9B¥63.9B¥74.7B¥85.1B¥96.7B
Intangible assets excluding goodwill¥947M¥1.15B¥2.17B¥1.95B¥1.92B
Investment securities¥47.8B¥44.7B¥51.2B¥41.9B¥46.1B
Current assets¥173.3B¥193.8B¥204.9B¥212B¥236.8B
Current liabilities¥50.5B¥51.6B¥54.1B¥58.3B¥86.2B
Trade payables¥21.3B¥18.5B¥21.7B¥22.3B¥21.4B
Short-term borrowings¥2B¥2.08B¥1.61B¥1.49B¥1.34B
Long-term borrowings¥610M¥2.33B¥2.77B¥2.01B¥1.96B
Total liabilities¥67.9B¥69.4B¥75.5B¥77.6B¥102.7B
Non-controlling interests¥777M¥825M¥904M¥1.02B¥1.12B
Equity attributable to owners of parent¥195.6B¥214.6B¥231.9B¥246.7B¥255.7B
Retained earnings¥166.1B¥192.1B¥206.3B¥220.2B¥249.2B
Treasury stock-¥3.29B-¥10.3B-¥7.21B-¥6.27B-¥26.3B

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    訂正有価証券報告書-第103期(2025/04/01-2026/03/31)

    ID S100YO712026-07-16Open
  • EDINET (FSA Japan)

    有価証券報告書-第102期(2024/04/01-2025/03/31)

    ID S100W41Q2025-06-26Open
  • EDINET (FSA Japan)

    有価証券報告書-第101期(2023/04/01-2024/03/31)

    ID S100TUSU2024-06-27Open
  • EDINET (FSA Japan)

    有価証券報告書-第100期(2022/04/01-2023/03/31)

    ID S100R2TO2023-06-27Open
  • EDINET (FSA Japan)

    有価証券報告書-第99期(令和3年4月1日-令和4年3月31日)

    ID S100OG8P2022-06-28Open
  • EDINET (FSA Japan)

    有価証券報告書-第98期(令和2年4月1日-令和3年3月31日)

    ID S100LSIH2021-06-29Open

Extracted from XBRL: 53 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.